Employees: 03 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2008-01-01 (18 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: PARIS (75013), Paris
APOTHICOM DISTRIBUTION : revenue, balance sheet and financial ratios
APOTHICOM DISTRIBUTION is a French company
founded 18 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in PARIS (75013),
this company of category PME
shows in 2021 a revenue of 7.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - APOTHICOM DISTRIBUTION (SIREN 501839971)
Indicator
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
7 845 820 €
5 518 204 €
5 208 683 €
4 127 001 €
3 860 432 €
3 399 060 €
Net income
730 446 €
831 374 €
1 140 637 €
1 129 058 €
1 022 473 €
352 404 €
445 161 €
409 831 €
EBITDA
N/C
N/C
870 489 €
807 237 €
890 973 €
664 961 €
776 189 €
655 534 €
Net margin
N/C
N/C
14.5%
20.5%
19.6%
8.5%
11.5%
12.1%
Revenue and income statement
In 2024, APOTHICOM DISTRIBUTION generates positive net income of 730 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 410 k€ -> 730 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
730 446 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 92%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1.481%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
91.889%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution APOTHICOM DISTRIBUTION
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Debt ratio
7.282
9.108
6.523
4.012
2.52
1.457
1.533
1.481
Financial autonomy
80.581
77.776
80.493
79.687
87.06
84.275
87.38
91.889
Repayment capacity
0.376
0.443
0.427
0.132
0.083
0.053
None
None
Cash flow / Revenue
14.076%
15.542%
12.098%
23.65%
24.376%
17.264%
None%
None%
Sector positioning
Debt ratio
1.482024
2021
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Good
In 2024, the debt ratio of APOTHICOM DISTRIBUTION (1.48) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
91.89%2024
2021
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Excellent+18 pts over 3 years
In 2024, the financial autonomy of APOTHICOM DISTRIBUTION (91.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.05 years2021
2021
Q1: 0.0 years
Med: 0.01 years
Q3: 1.79 years
Average
In 2021, the repayment capacity of APOTHICOM DISTRIBUTION (0.05) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 1346.87. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
1346.873
Liquidity indicators evolution APOTHICOM DISTRIBUTION
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Liquidity ratio
553.163
389.892
461.422
409.459
692.022
552.016
815.975
1346.873
Interest coverage
0.68
1.177
1.028
0.612
0.838
0.345
None
None
Sector positioning
Liquidity ratio
1346.872024
2021
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Excellent
In 2024, the liquidity ratio of APOTHICOM DISTRIBUTION (1346.87) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.34x2021
2021
Q1: 0.0x
Med: 0.39x
Q3: 4.57x
Average
In 2021, the interest coverage of APOTHICOM DISTRIBUTION (0.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution APOTHICOM DISTRIBUTION
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Operating WCR
1 149 766 €
1 093 545 €
1 392 698 €
2 209 940 €
1 677 368 €
2 023 986 €
0 €
0 €
Inventory turnover (days)
39
29
31
46
39
21
0
0
Customer payment term (days)
47
58
62
88
59
61
0
0
Supplier payment term (days)
31
56
42
36
28
33
0
0
Positioning of APOTHICOM DISTRIBUTION in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of APOTHICOM DISTRIBUTION is estimated at
600 072 €
(range 228 392€ - 2 191 389€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
124 transactions
228k€600k€2191k€
600 072 €Range: 228 392€ - 2 191 389€
NAF 5 all-time
Valuation method used
Net Income Multiple
730 446 €
×
0.8x
=600 073 €
Range: 228 392€ - 2 191 390€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare APOTHICOM DISTRIBUTION with other companies in the same sector:
Frequently asked questions about APOTHICOM DISTRIBUTION
What is the revenue of APOTHICOM DISTRIBUTION ?
The revenue of APOTHICOM DISTRIBUTION in 2021 is 7.8 M€.
Is APOTHICOM DISTRIBUTION profitable?
Yes, APOTHICOM DISTRIBUTION generated a net profit of 730 k€ in 2024.
Where is the headquarters of APOTHICOM DISTRIBUTION ?
The headquarters of APOTHICOM DISTRIBUTION is located in PARIS (75013), in the department Paris.
Where to find the tax return of APOTHICOM DISTRIBUTION ?
The tax return of APOTHICOM DISTRIBUTION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does APOTHICOM DISTRIBUTION operate?
APOTHICOM DISTRIBUTION operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart